行情

OCX

OCX

ONCOCYTE
AMEX

实时行情|Nasdaq Last Sale

1.780
+0.040
+2.30%
盘后: 1.780 0 0.00% 16:00 12/06 EST
开盘
1.770
昨收
1.740
最高
1.820
最低
1.700
成交量
19.02万
成交额
--
52周最高
6.92
52周最低
1.165
市值
6,731.64万
市盈率(TTM)
-4.4780
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

OCX 新闻

  • 意大利再次修正2020财政预算案 推多项惠民政策
  • 中国新闻网.5天前
  • 兴业银行:美国国债收益率或将因衰退风险而跌至1.2%
  • 新浪财经综合.5天前
  • 波音737 MAX审查进展:FAA局长将赴众院说明情况
  • 中国新闻网.5天前
  • 美股超级牛派:最近的下跌是早来的圣诞礼物
  • 新浪财经.5天前

更多

所属板块

生物技术和医学研究
+0.66%
制药与医学研究
+0.49%

热门股票

名称
价格
涨跌幅

OCX 简况

OncoCyte Corporation is a development-stage biotechnology company focused in the field of regenerative medicine. The Company is developing molecular cancer diagnostics utilizing a discovery platform that focuses on identifying genetic markers expressed in various types of cancer. It operates through the research and development of diagnostic tests for the detection of cancer segment. Its initial focus will be confirmatory diagnostics, utilizing liquid biopsy technology, for use in conjunction with imaging to confirm initial diagnoses within certain oncology indications. In addition, it will be developing screening diagnostics as replacements for screening imaging procedures. For some indications, it will also be pursuing the probability of recurrence of a specific cancer through the development of prognostics or companion diagnostics that help a physician determine which therapy is the optimal treatment for the patient. It offers diagnostic tests for lung, breast and bladder cancer.
展开

Webull提供OncoCyte Corp的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。